Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IceCure Medical (ICCM) Operating Leases (2020 - 2026)

IceCure Medical has reported Operating Leases over the past 7 years, most recently at $5000.0 for Q1 2026.

  • For Q1 2026, Operating Leases changed N/A year-over-year to $5000.0; the TTM value through Mar 2026 reached $5000.0, changed N/A, while the annual FY2025 figure was $13000.0, 97.17% down from the prior year.
  • Operating Leases was $5000.0 for Q1 2026 at IceCure Medical, down from $13000.0 in the prior quarter.
  • Across five years, Operating Leases topped out at $459000.0 in Q4 2024 and bottomed at $5000.0 in Q1 2026.
  • The 5-year median for Operating Leases is $376000.0 (2023), against an average of $256600.0.
  • Year-over-year, Operating Leases grew 22.07% in 2024 and then crashed 97.17% in 2025.
  • Over 5 years, Operating Leases stood at $430000.0 in 2022, then decreased by 12.56% to $376000.0 in 2023, then grew by 22.07% to $459000.0 in 2024, then crashed by 97.17% to $13000.0 in 2025, then plummeted by 61.54% to $5000.0 in 2026.
  • The last three reported values for Operating Leases were $5000.0 (Q1 2026), $13000.0 (Q4 2025), and $459000.0 (Q4 2024) per Business Quant data.